Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What key factors are powering the surge in the genomic biomarkers market right now?

The genomic biomarkers market has experienced rapid growth, expected to grow from $7.42 billion in 2024 to $8.72 billion in 2025, with a CAGR of 17.4%. Growth drivers include the rising emphasis on genetic testing, increasing cases of chronic diseases, precision medicine initiatives, growing adoption of companion diagnostics, and a surge in neurological disease cases.

How fast Is the genomic biomarkers market expected to grow, and what’s its future value?

The genomic biomarkers market is projected to grow significantly, reaching $16.51 billion by 2029 at a CAGR of 17.3%. Growth drivers include rising ovarian and gastric cancer cases, increasing awareness of genetic testing, greater use of biomarkers in cancer diagnosis and treatment, and adoption of companion diagnostics. Major trends include advancements in NGS, integration with omics technologies, product innovations, genomic technology improvements, and enhanced healthcare services.

Get your genomic biomarkers market report here!

https://www.thebusinessresearchcompany.com/report/genomic-biomarkers-global-market-report

What are the leading drivers of growth in the genomic biomarkers market?

The increasing demand for personalized medicine is expected to propel the genomic biomarkers market. Personalized medicine, which tailors medical treatment to the individual characteristics of patients, is gaining traction due to advancements in genetic analysis and the growing focus on patient-centered care. Genomic biomarkers are essential for personalized medicine, as they help customize treatments based on a patient’s genetic profile. For example, in 2022, the Personalized Medicine Coalition reported that 12 new personalized therapies were approved, accounting for 34% of all new treatments. This rising demand for personalized medicine is driving the genomic biomarkers market.

What are the key segments defining the genomic biomarkers market?

The genomic biomarkersmarket covered in this report is segmented –

1) By Type: Predictive Biomarkers, Prognostic Biomarkers

2) By Disease Indication: Oncology, Cardiovascular Diseases, Neurological Diseases, Renal Disorders, Other Disease Indications

3) By Validation: Analytical Validation, Clinical Validation, Clinical Utility

4) By End-User: Hospitals, Diagnostic Centers, Other End User

Subsegments:

1) By Predictive Biomarkers: Drug Response Biomarkers, Companion Diagnostics Biomarkers, Pharmacodynamic Biomarkers, Predictive Genetic Markers for Disease Susceptibility

2) By Prognostic Biomarkers: Cancer Prognostic Biomarkers, Cardiovascular Disease Prognostic Biomarkers, Neurodegenerative Disease Prognostic Biomarkers, Infectious Disease Prognostic Biomarkers

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19485&type=smp

Who are the key players steering the development of the genomic biomarkers market?

Major companies operating in the genomic biomarkers market are Thermo Fisher Scientific Inc., Roche Diagnostics International Ltd., Illumina Inc., PerkinElmer Inc., Almac Group, Azenta Inc., Novogene Corporation, Oxford Nanopore Technologies Ltd., Celerion, Quanterix Corporation, Bio-Rad Laboratories Inc., NantHealth Inc., Centogene N.V., Sophia Genetics SA, Envisagenics, Deep Genomics, Creative Diagnostics, Macrogen Inc., Guardant Health Inc., Sema4

What emerging trends are influencing the growth of the genomic biomarkers market?

Leading firms in the genomic biomarkers market are honing in on the creation of novel products such as lung reagents. Featured in diagnostic tests, research, and medical procedures connected with the lungs, these substances expedite precision medicine through guiding treatment decisions that take into account the distinct genetic composition of a cancer. They are designed to pinpoint genetic mutations specific to lung cancer which are essential in directing targeted therapies and personalised treatment plans. Integral to this innovation is the employment of cutting-edge genomic technologies aimed to boost diagnostic precision. An exemplar of this is Biofidelity, a UK-based company with specialisation in the advancement of genomic assays and precision diagnostics. In December 2023, Biofidelity released their ASPYRE-Lung reagents in pursuit of enhancing detection and treatment strategies for lung cancer.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19485

Which regions are most influential in expanding the genomic biomarkers market?

North America was the largest region in the genomic biomarkers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genomic biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Non-Alcoholic Steatohepatitis Biomarkers Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/non-alcoholic-steatohepatitis-biomarkers-global-market-report

Single-Cell Genome Sequencing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/single-cell-genome-sequencing-global-market-report

Cardiac Biomarkers Testing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-testing-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: